Cargando…
The Predictive Value of Three Variables in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis
BACKGROUND: Sex, age, and International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic risk may influence the immune response. Nonetheless, the correlation between these factors and the survival benefits of immune-based combination therapies in patients with metastatic renal c...
Autores principales: | Hou, Min, Xing, Haiyan, He, Shuangshuang, Yang, Xue, Peng, Dan, Li, Yang, Zhang, Qing, Zhang, Pan, Ma, Yunqi, Li, Juan, Shan, Jinlu, Liu, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482552/ https://www.ncbi.nlm.nih.gov/pubmed/36124031 http://dx.doi.org/10.1155/2022/7733251 |
Ejemplares similares
-
Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
por: Luo, Xiaofeng, et al.
Publicado: (2023) -
The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
por: Yang, Jin-Ru, et al.
Publicado: (2022) -
Clinical values of urinary IL-6 in asymptomatic renal hematuria and renal hematuria with proteins
por: SONG, MINGHUI, et al.
Publicado: (2013) -
Is Ivermectin Effective in Treating COVID-19?
por: Yang, Shuangshuang, et al.
Publicado: (2022) -
A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma
por: Syed, Mohsan Ali, et al.
Publicado: (2017)